Therapeutic antibodies for the treatment of pancreatic cancer. - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles TheScientificWorldJournal Year : 2010

Therapeutic antibodies for the treatment of pancreatic cancer.

Patrick Chames
Connectez-vous pour contacter l'auteur
Brigitte Kerfelec
Daniel Baty
  • Function : Author

Abstract

Pancreatic cancer is a devastating disease with the worst mortality rate and an overall 5-year survival rate lower than 5%. In the U.S., this disease is the fourth leading cause of death and represents 6% of all cancer-related deaths. Gemcitabine, the current standard first-line treatment, offers marginal benefits to patients in terms of symptom control and prolongation of life. Since 1996, about 20 randomized phase III trials have been performed to improve the efficacy of gemcitabine, with little success regarding a significant improvement in survival outcomes. The need for novel therapeutic strategies, such as target therapy, is obvious. Monoclonal antibodies have finally come of age as therapeutics and several molecules are now approved for cancer therapies. This review aims to give a general view on the clinical results obtained so far by antibodies for the treatment of pancreatic cancer and describes the most promising avenues toward a significant improvement in the treatment of this frustrating disease.
Fichier principal
Vignette du fichier
Chames_TSWJ.pdf (434.25 Ko) Télécharger le fichier
inserm-00497886_edited.pdf (179.47 Ko) Télécharger le fichier
Origin : Files produced by the author(s)
Origin : Files produced by the author(s)
Loading...

Dates and versions

inserm-00497886 , version 1 (06-07-2010)

Identifiers

Cite

Patrick Chames, Brigitte Kerfelec, Daniel Baty. Therapeutic antibodies for the treatment of pancreatic cancer.: Mabs against pancreatic cancer. TheScientificWorldJournal, 2010, 10, pp.1107-20. ⟨10.1100/tsw.2010.103⟩. ⟨inserm-00497886⟩

Collections

INSERM UNIV-AMU
63 View
614 Download

Altmetric

Share

Gmail Facebook X LinkedIn More